Your session is about to expire
← Back to Search
Device
Female subjects referred for percutaneous coronary intervention for Coronary Artery Disease (EMPOWER CAD Trial)
N/A
Recruiting
Research Sponsored by Shockwave Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-24 hours post procedure or at discharge, whichever is earlier, but at least 6 hours post procedure
Awards & highlights
Summary
Post-market, prospective, multi-center, single-arm observational study to generate real-world clinical evidence associated with coronary IVL in a population of female subjects with calcified coronary artery disease.
Eligible Conditions
- Coronary Artery Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12-24 hours post procedure or at discharge, whichever is earlier, but at least 6 hours post procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-24 hours post procedure or at discharge, whichever is earlier, but at least 6 hours post procedure
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Primary Effectiveness Endpoint
Primary Safety Endpoint
Trial Design
1Treatment groups
Experimental Treatment
Group I: Female subjects referred for percutaneous coronary interventionExperimental Treatment1 Intervention
Female subjects referred for percutaneous coronary intervention (PCI) with coronary IVL and stenting per standard of care.
Find a Location
Who is running the clinical trial?
Shockwave Medical, Inc.Lead Sponsor
30 Previous Clinical Trials
8,959 Total Patients Enrolled
10 Trials studying Coronary Artery Disease
3,390 Patients Enrolled for Coronary Artery Disease
Share this study with friends
Copy Link
Messenger